No nit-picking from FDA on new lice drug
Executive Summary
Sciele Pharma's benzyl alcohol lotion, 5 percent received FDA approval April 9 for the treatment of head lice in patients six months of age and older, making it the first head lice product approved by the agency with benzyl alcohol as the active pharmaceutical ingredient. Approval was based on two placebo-controlled studies of 628 subjects with active head lice infestation; 14 days following the final treatment, more than 75 percent of the subjects treated with the drug were lice-free